BRCA2 Gene
protein-coding GIFtS: 68
GCID: GC13P032889
|
|
breast cancer 2, early onset(Previous names: Fanconi anemia, complementation group D1 ) (Previous symbols: FANCD1, FACD, FANCD)
| |
Aliases for BRCA2 gene
(According to
1HGNC,
2Entrez Gene,
3UniProtKB/Swiss-Prot,
4UniProtKB/TrEMBL, 5OMIM, 6GeneLoc,
7Ensembl,
8DME,
9miRBase,
and/or 10fRNAdb) About This Section
|
| Aliases |
|---|
| Breast Cancer 2, Early Onset1 2 | | GLM32 5 | | FANCD11 2 3 5 | | PNCA22 5 | | FACD1 2 3 | | Fanconi Anemia, Complementation Group D11 | | BRCC21 2 | | FANCB2 | | FAD1 2 | | BRCA1/BRCA2-Containing Complex, Subunit 22 | | FAD11 2 | | Breast And Ovarian Cancer Susceptibility Gene, Early Onset2 | | FANCD1 2 | | Breast Cancer 2 Tumor Suppressor2 | | Fanconi Anemia Group D1 Protein2 3 | | Breast Cancer Type 2 Susceptibility Protein2 | | BROVCA22 5 | | Truncated Breast And Ovarian Cancer Susceptibility Protein 22 |
Export aliases for BRCA2 gene to outside databasesPrevious GC identifers: GC13P030875 GC13P026876 GC13P031826 GC13P030687 GC13P031787 GC13P013701 |
Summaries for BRCA2 gene(According to Entrez Gene,
Tocris Bioscience,
Wikipedia's
Gene Wiki,
PharmGKB,
UniProtKB/Swiss-Prot,
and/or
UniProtKB/TrEMBL)
About This Section
| Entrez Gene summary for BRCA2: Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovariancancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologousrecombination pathway for double-strand DNA repair. The BRCA2 protein contains several copies of a 70 aa motif calledthe BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 isconsidered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) ofthe wild-type allele. (provided by RefSeq, Dec 2008) UniProtKB/Swiss-Prot: BRCA2_HUMAN, P51587Function: Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiatesrecombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 tossDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizingRAD51-ssDNA filaments by blocking ATP hydrolysis. May participate in S phase checkpoint activation. Binds selectivelyto ssDNA, and to ssDNA in tailed duplexes and replication fork structures. In concert with NPM1, regulates centrosomeduplication Gene Wiki entry for BRCA2
|
Genomic Views for BRCA2 gene
(According to
GeneLoc and/or
HGNC, and/or
Entrez Gene (NCBI build 37),
and/or miRBase,
Genomic Views according to
UCSC (hg19) and
Ensembl (release 69),
Regulatory elements and Epigenetics data according to
QIAGEN,
SABiosciences, and/or
SwitchGear Genomics) About This Section
| RefSeq DNA sequence:- NC_000013.10 NC_018924.1 NT_024524.14
Regulatory elements: SABiosciences Regulatory transcription factor binding sites in the BRCA2 gene promoter: GR NF-1 AML1a CREB MEF-2A Nkx6-1 deltaCREB POU2F1c GR-alpha aMEF-2 Other transcription factors
Search SABiosciences Chromatin IP Primers for BRCA2
Epigenetics:
|  | QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat BRCA2 |
Genomic Location: Genomic View: UCSC Golden Path with GeneCards custom track
Entrez Gene cytogenetic band: 13q12.3 Ensembl cytogenetic band: 13q13.1 HGNC cytogenetic band: 13q12-q13BRCA2 Gene in genomic location: bands according to Ensembl, locations according to
(and/or Entrez Gene and/or Ensembl if different)

GeneLoc information about chromosome 13 GeneLoc Exon Structure GeneLoc location for GC13P032889: view genomic region
(about GC identifiers)
Start:
|
32,889,611 bp from pter |
End:
|
32,973,809 bp from pter |
Size:
|
84,199 bases |
Orientation:
|
plus strand |
|
Proteins for BRCA2 gene
(According to
1UniProtKB,
HORDE,
neXtProt,
Ensembl,
and/or Reactome,
Modification sites according to 2PhosphoSitePlus,
Specific Peptides from DME,
Protein expression images according to data from SPIRE MOPED and PaxDb,
RefSeq according to NCBI,
PDB rendering according to OCA and/or Proteopedia,
Recombinant Proteins
from
EMD Millipore,
R&D Systems,
GenScript,
Enzo Life Sciences,
OriGene,
Novus Biologicals,
Sino Biological,
ProSpec, and/or
Uscn,
Biochemical Assays by
EMD Millipore,
R&D Systems,
OriGene,
GenScript,
Cell Signaling Technology,
Enzo Life Sciences, and/or
Uscn,
Ontologies according to Gene
Ontology Consortium 01 Mar 2013 and
Entrez Gene,
Antibodies by
EMD Millipore,
R&D Systems,
GenScript,
Cell Signaling Technology,
OriGene,
Novus Biologicals,
Thermo Fisher Scientific,
Abcam, and/or
Uscn)
About This Section
| UniProtKB/Swiss-Prot: BRCA2_HUMAN, P51587 (See
protein sequence)Recommended Name: Breast cancer type 2 susceptibility protein Size: 3418 amino acids; 384225 Da
Subunit: Monomer and dimer. Interacts with RAD51; regulates RAD51 recruitment and function at sites of DNA repair.Interacts with DSS1. Interacts with both nonubiquitinated and monoubiquitinated FANCD2; this complex also includesXRCC3 and phosphorylated FANCG. Interacts with WDR16. Interacts with USP11. Interacts with DMC1. Part of a trimericcomplex containing BRCA1, BRCA2 and PALB2. Interacts with PALB2. Interacts with BRCA1 only in the presence of PALB2which serves as the bridging protein. Interacts with ROCK2 and NPM1
2 PDB 3D structures from and Proteopedia for BRCA2:1N0W (3D)
  3EU7 (3D)
 
Secondary accessions: O00183 O15008 Q13879 Q5TBJ7Explore the universe of human proteins at neXtProt for BRCA2: NX_P51587
Post-translational modifications:
Phosphorylated by ATM upon irradiation-induced DNA damage. Phosphorylation by CHEK1 and CHEK2 regulates interactionwith RAD51. Phosphorylation at Ser-3291 by CDK1 and CDK2 is low in S phase when recombination is active, but increasesas cells progress towards mitosis; this phosphorylation prevents homologous recombination-dependent repair during Sphase and G2 by inhibiting RAD51 binding1
Ubiquitinated in the absence of DNA damage; this does not lead to proteasomal degradation. In contrast, ubiquitinationin response to DNA damage leads to proteasomal degradation1
View modification sites using PhosphoSitePlus2View neXtProt modification sites for NX_P51587 BRCA2 Protein expression data from MOPED and PaxDb: About this image 
REFSEQ proteins: NP_000050.2 ENSEMBL proteins: ENSP00000369497 ENSP00000435699 ENSP00000433168 ENSP00000434898 ENSP00000439902 Reactome Protein details: P51587 Human Recombinant Protein Products:
Gene Ontology (GO): 5/8 cellular component terms (GO ID links to tree view) (see all 8): About this table
BRCA2 for ontologies About GeneDecksing
BRCA2 Antibody Products: Assay Products for BRCA2: |
Protein
Domains / Families for BRCA2 gene(According to InterPro, ProtoNet,
UniProtKB, and/or BLOCKS,
Sets of similar genes according to GeneDecks)
About This Section
|
BRCA2 for domains About GeneDecksing
5/7 InterPro domains/families (see all 7):Graphical View of Domain Structure for InterPro Entry P51587ProtoNet protein and cluster: P51587 UniProtKB/Swiss-Prot: BRCA2_HUMAN, P51587Similarity: Contains 8 BRCA2 repeats |
Function for BRCA2 gene
(According to 1UniProtKB,
Genatlas,
LifeMap Discovery™,
IUBMB, and/or
2DME,
Human phenotypes from GenomeRNAi,
Animal models from MGI Mar 06 2013,
bound targets from SABiosciences,
miRNA Gene Targets from miRTarBase
shRNA from
OriGene,
RNAi from
EMD Millipore,
siRNAs from
OriGene,
QIAGEN,
microRNA from QIAGEN,
Gene Editing from DNA2.0,
Clones from EMD Millipore,
OriGene,
SwitchGear Genomics,
GenScript,
Sino Biological,
DNA2.0,
and Vector BioLabs,
Cell Lines from GenScript,
LifeMap BioReagents,
In Situ Hybridization Assays from Advanced Cell Diagnostics,
Ontologies according to Gene Ontology Consortium 01 Mar 2013 via
Entrez Gene.)
About This Section
| Function Summary: UniProtKB/Swiss-Prot: BRCA2_HUMAN, P51587Function: Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiatesrecombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 tossDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizingRAD51-ssDNA filaments by blocking ATP hydrolysis. May participate in S phase checkpoint activation. Binds selectivelyto ssDNA, and to ssDNA in tailed duplexes and replication fork structures. In concert with NPM1, regulates centrosomeduplication Genatlas biochemistry entry for BRCA2:BRCA2 homolog to C elegans T07E3 uncharacterized gene,expressed in many tissues and most abundant in the Sphase,complexing and interacting with phosphorylated BRCA1,RAD51 and RAD52 for cell cycle control and DNA repairthrough homologous recombination,also involved in embryonic cellular proliferation
Clone Products: |  | Browse Clones for the Expression of Recombinant Proteins Available from EMD Millipore | |  | OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for BRCA2 (see all 3) OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for BRCA2 OriGene custom cloning services – gene synthesis, subcloning, mutagenesis,
variant library, vector shuttling 
| |  | GenScript: all cDNA clones in your preferred vector: BRCA2 (NM_000059) | |  | Sino Biological Human cDNA Clone for BRCA2 | |  | DNA2.0 Custom Codon Optimized Gene
Synthesis Service for BRCA2 | |  | Search Vector BioLabs for ready-to-use adenovirus/AAV for human, mouse, rat BRCA2  |
In Situ Assay Products: |
| Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for BRCA2 |
Gene Ontology (GO): 5/7 molecular function terms (GO ID links to tree view) (see all 7): About this table
BRCA2 for ontologies About GeneDecksing
5 GenomeRNAi human phenotypes for BRCA2: Animal Models: Mouse knock-outs for BRCA2: Brca2tm1Mbn Brca2tm1Kamc Brca2tm1Arge Brca2tm1Cbl Brca2tm1Mhun Brca2tm1Hst Brca2tm1.1Brn Brca2tm1Mak Brca2tm2Hst Brca2tm1Brd 15/17 MGI mutant phenotypes (inferred from 15 alleles ) (MGI details for Brca2) (see all 17):
BRCA2 for phenotypes About GeneDecksing
|
Pathways & Interactions for BRCA2 gene
(Pathways according to
EMD Millipore,
R&D Systems,
Cell Signaling Technology,
KEGG,
PharmGKB,
BioSystems,
Reactome,
Tocris Bioscience,
GeneGo (Thomson Reuters),
QIAGEN,
and/or UniProtKB,
Sets of similar genes according to GeneDecks,
Interaction Networks according to
SABiosciences,
and/or STRING,
Interactions according to 1UniProtKB,
2MINT,
3I2D, and/or
4STRING,
with links to IntAct and
Ensembl,
Ontologies according to Gene Ontology Consortium 01 Mar 2013 via
Entrez Gene).
About This Section
| Unified GeneCards pathways - 5/19 super-pathways (see all 19) About this table  See pathways by source
| Super-pathway | contained gene-specific pathways |
|---|
| 1 | Formation of Meiotic Holliday Junction | | | 2 | Homologous Recombination Repair | | | 3 | Fanconi Anemia pathway | | | 4 | Integrated Pancreatic Cancer Pathway | | | 5 | Homologous recombination | |
Pathway sources See GeneCards unified pathways Show all pathways
1 EMD Millipore Pathway for BRCA2 4 Downloadable PowerPoint Slides of QIAGEN Pathway Central Maps for BRCA2 2
Cell Signaling Technology (CST) Pathways for BRCA2 1 GeneGo (Thomson Reuters) Pathway for BRCA2 5/6 BioSystems Pathways for BRCA2 (see all 6) 
5/13
Reactome Pathways for BRCA2 (see all 13)
3
Kegg Pathways (Kegg details for BRCA2):
BRCA2 for pathways About GeneDecksing
Interactions:
SABiosciences Gene Network CentralTM Interacting Genes and Proteins Network for BRCA2
STRING Interaction
Network Preview (showing 5 interactants - click image to see 25)
 5/92 Interacting proteins for BRCA2 (P515871, 2, 3 ENSP000003694974) via UniProtKB, MINT, STRING, and/or I2D (see all 92)| Interactant | Interaction Details |
|---|
| GeneCard | External ID(s) |
|---|
| RAD51 | Q066091, 2, 3, ENSP000002678684 | EBI-79792,EBI-1059207 MINT-8176347 MINT-8361862 MINT-8384735 MINT-4980518 MINT-8329250 MINT-8303499 MINT-4980488 MINT-4980408 MINT-8384781 MINT-8385051 MINT-8385019 MINT-8384801 MINT-8384999 MINT-8329389 MINT-8176308 MINT-4980796 MINT-4980473 MINT-8329289 MINT-8176323 MINT-4980567 MINT-8384752 MINT-4980502 I2D:
score=10 STRING: ENSP00000267868 | | PALB2 | Q86YC22, 3, ENSP000002615844 | MINT-8361862 MINT-8385019 MINT-8384999 MINT-8329389 MINT-8329250 MINT-8329289 MINT-8384768 MINT-7262259 MINT-7262208 MINT-8384781 MINT-7262197 MINT-7262227 I2D:
score=3 STRING: ENSP00000261584 | | PDS5B | Q9NTI52 | MINT-8384735 MINT-8392646 MINT-8384678 MINT-8384908 MINT-8384717 MINT-8392542 MINT-8384781 MINT-8384942 MINT-8384857 MINT-8392595 MINT-8384958 MINT-8385051 MINT-8392612 MINT-8384892 MINT-8385019 MINT-8384999 MINT-8385117 MINT-8385079 MINT-8384691 MINT-8391711 MINT-8392578 MINT-8384926 MINT-8385033 MINT-8392560 MINT-8385100 MINT-8392629 | | DMC1 | Q145652, 3, ENSP000002160244 | MINT-4980903 MINT-4980810 MINT-4980826 MINT-4980585 MINT-4980429 MINT-4980889 MINT-4980408 MINT-4980860 MINT-4980845 MINT-4980457 MINT-4980775 I2D:
score=1 STRING: ENSP00000216024 | | BRCA1 | P383982, 3, ENSP000003502834 | MINT-8361862 MINT-8329389 MINT-8329250 MINT-8329289 I2D:
score=5 STRING: ENSP00000350283 | About this table
Gene Ontology (GO): 5/37 biological process terms (GO ID links to tree view) (see all 37): About this table
BRCA2 for ontologies About GeneDecksing
|
Drugs & Compounds for BRCA2 gene(Chemical Compounds according to UniProtKB, Enzo Life Sciences,
EMD Millipore, Tocris Bioscience
HMDB,
BitterDB, and/or
Novoseek, and Drugs according to
DrugBank,
Enzo Life Sciences, and/or
PharmGKB, with drugs/clinical trials/news
search links to CenterWatch)
About This Section
|
BRCA2 for compounds About GeneDecksing
Browse Tocris compounds for BRCA2 10/48 Novoseek chemical compound relationships for BRCA2 gene (see all 48) About this table
| Compound |
-log (P-Val) |
Hits |
PubMed IDs for Articles with Shared Sentences (# sentences) |
| nu1025 |
65.2 |
3 |
16251802 (1), 18990703 (1) |
| tamoxifen |
60.3 |
33 |
11710890 (5), 11130383 (4), 14645421 (4), 11870509 (3) (see all 19) |
| estrogen |
54.4 |
40 |
8895509 (5), 18765668 (3), 18086271 (2), 15381448 (2) (see all 22) |
| mitomycin c |
42.4 |
32 |
20174566 (3), 15314155 (2), 18469443 (2), 16920162 (2) (see all 16) |
| progesterone |
39.1 |
12 |
14732925 (2), 11429050 (1), 12548582 (1), 15933754 (1) (see all 11) |
| adpribose |
26.1 |
3 |
19074863 (1), 16082177 (1), 19553641 (1) |
| camptothecin |
17.9 |
10 |
12007633 (1), 15258697 (1), 9679765 (1), 12673354 (1) (see all 7) |
| 3-aminobenzamide |
11.9 |
2 |
16251802 (1) |
| daidzein |
11.1 |
7 |
12881020 (3), 20127002 (2), 11694309 (1) |
| cisplatin |
5.31 |
19 |
19654294 (5), 18264087 (4), 10446958 (1), 18413725 (1) (see all 6) |
Search CenterWatch for drugs/clinical trials and news about BRCA2 
|
Transcripts for BRCA2 gene(Secondary structures according to
fRNAdb,
GenBank/EMBL/DDBJ Accessions according to
Unigene
(Build 235 Homo sapiens; Mar 10 2013) or GenBank, RefSeq according to Entrez Gene,
DOTS (version 10), and/or
AceView,
transcript ids from Ensembl
with links to UCSC,
exon structure from GeneLoc,
alternative splicing isoforms according to ASD and/or
ECgene,
RNAi Products from
EMD Millipore,
siRNAs from
OriGene,
QIAGEN,
shRNA from
OriGene,
microRNA from QIAGEN,
Tagged/untagged cDNA clones from
OriGene,
SwitchGear Genomics,
GenScript,
DNA2.0,
Vector BioLabs,
Primers from
OriGene,
SABiosciences, and/or
QIAGEN
) About This Section
| REFSEQ mRNAs for BRCA2 gene: NM_000059.3 Unigene Cluster for BRCA2: Breast cancer 2, early onset Hs.34012 [show with all ESTs]Unigene Representative Sequence: NM_0000596 Ensembl transcripts including schematic representations, and UCSC links where relevant: ENST00000380152(uc001uua.1) ENST00000530893 ENST00000528762 ENST00000470094 ENST00000533776 ENST00000544455(uc001uub.1)
Clone Products: |  | OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for BRCA2 (see all 3) OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for BRCA2 OriGene custom cloning services – gene synthesis, subcloning, mutagenesis,
variant library, vector shuttling 
| |  | GenScript: all cDNA clones in your preferred vector: BRCA2 (NM_000059) | |  | DNA2.0 Custom Codon Optimized Gene
Synthesis Service for BRCA2 | |  | Search Vector BioLabs for ready-to-use adenovirus/AAV for human, mouse, rat BRCA2  |
Additional cDNA sequence: BC026160.1 BC047568.1 DQ897648.1 3 DOTS entries: DT.212055 DT.91725304 DT.40111537 24/48 AceView cDNA sequences (see all 48): NM_000059 BQ439258 AL044849 BC026160 BC047568 AL602008 BX102368 AI355687 U43746 BQ226936 H48122 AU143426 CF143354 BM839248 BG290037 AA741449 AL601892 AI688632 BU568005 BG773127 AA767988 BX496533 AA215820 BM171992 GeneLoc Exon Structure
|
Expression for BRCA2 gene
(RNA expression data according to
H-InvDB,
NONCODE,
miRBase, and
RNAdb,
Expression images according to data from
BioGPS,
Illumina Human BodyMap, and
CGAP
SAGE,
Sets of similar genes according to GeneDecks,
in vivo and in vitro expression data from LifeMap Discovery™,
plus additional links to
Genevestigator, and/or
SOURCE, and/or
BioGPS, and/or
UniProtKB,
PCR Arrays from
SABiosciences,
Primers from
OriGene,
SABiosciences, and/or
QIAGEN,
In Situ Hybridization Assays from Advanced Cell Diagnostics)
About This Section
| BRCA2 expression in normal human tissues (normalized intensities) See probesets specificity/sensitivity at GeneAnnot About this imageBioGPS CGAP TAG: ATTATAAGAA
About this image See BRCA2 Protein Expression from SPIRE MOPED and PaxDB Genevestigator expression for BRCA2
SOURCE GeneReport for Unigene cluster: Hs.34012 UniProtKB/Swiss-Prot: BRCA2_HUMAN, P51587Tissue specificity: Highest levels of expression in breast and thymus, with slightly lower levels in lung, ovary andspleen SABiosciences Expression via Pathway-Focused PCR Arrays including BRCA2 (see all 10):
Primer Products: |  | OriGene genome-wide validated SYBR primer pairs in human, mouse, rat for BRCA2 Browse OriGene validated miRNA SYBR primer pairs
| |  | SABiosciences RT2 qPCR Primer Assay in human, mouse, rat BRCA2 | |  | QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat BRCA2 | |  | QIAGEN QuantiFast Probe-based Assays in human, mouse, rat BRCA2 | In Situ Assay Products: |
| Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for BRCA2 |
Orthologs for BRCA2 gene
(Orthologs according to
1,2HomoloGene (2older version, for species not in 1newer version),
3euGenes,
4SGD
,
5MGI Mar 06 2013,
with possible further links to
Flybase
and/or
WormBase,
and/or
6Ensembl pan taxonomic compara ,
Gene Trees according to Ensembl and
TreeFam)
About This Section
|
This gene was present in the common ancestor of eukaryotes.
Orthologs for BRCA2 gene from 7/18 species (see all 18) About this table
ENSEMBL Gene Tree for BRCA2 (if available) TreeFam Gene Tree for BRCA2 (if available)  |
Paralogs for BRCA2 gene(Paralogs according to
1HomoloGene, 2Ensembl, and 3SIMAP, Pseudogenes according to 4Pseudogene.org Build 68) About This Section
| -- |
Genomic Variants for BRCA2 gene(SNPs/Variants according to the
1NCBI SNP Database,
2Ensembl,
3PupaSUITE,
UniProtKB, and
DNA2.0,
Linkage Disequilibrium by HapMap,
Structural Variations(CNVs/InDels/Inversions) from the Database of Genomic Variants, Mutations from the Human Gene
Mutation Database (HGMD) and the Locus Specific Mutation
Databases (LSDB), Blood group antigen gene mutations by BGMUT,
Resequencing Primers from QIAGEN,
Cancer Mutation PCR Arrays and Assays and Copy Number PCR Arrays from SABiosciences)
About This Section
|
| Genomic Data | Transcription Related Data | Allele Frequencies | | SNP ID | Valid | Clinical significance | Chr 13 pos | Sequence | # | AA Chg | Type | More | # | Allele freq | Pop | Total sample | More |
|---|
HapMap Linkage Disequilibrium report for BRCA2 (32889611 - 32973809 bp)
Structural Variations (Copy Number Variations, Insertions/Deletions, Inversions) Database of Genomic Variants (DGV): 1 variation for BRCA2 1 Indel: 58621 Human Gene Mutation Database (HGMD): BRCA2
Locus Specific Mutation Databases (LSDB): BRCA2
 | 2 SABiosciences Cancer Mutation PCR Assays for BRCA2: |
 | 1 SABiosciences qBiomarker Copy Number PCR Array containing BRCA2: |
|  | QIAGEN SeqTarget long-range PCR primers in human, mouse, rat for resequencing BRCA2 |
|
Disorders
/ Diseases for BRCA2 gene
(in which this Gene is Involved, According to MalaCards,
OMIM, UniProtKB,
the University of Copenhagen DISEASES
database, Novoseek,
Genatlas, GeneTests,
GAD,
HuGE Navigator,
and/or TGDB.)
About This Section
|
BRCA2 for disorders About GeneDecksing
OMIM gene information: 600185 OMIM disorders: 612555 605724 176807 114480 194070 155255 613029 613347 UniProtKB/Swiss-Prot: BRCA2_HUMAN, P51587
Defects in BRCA2 are a cause of susceptibility to breast cancer (BC) [MIM:114480]. A common malignancyoriginating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasiveductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous.Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more thanone locus can be involved in different families or even in the same case Defects in BRCA2 are the cause of pancreatic cancer type 2 (PNCA2) [MIM:613347]. It is a malignant neoplasm ofthe pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them developfrom the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue Defects in BRCA2 are a cause of susceptibility to familial breast-ovarian cancer type 2 (BROVCA2)[MIM:612555]. A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristicfeatures in affected families are an early age of onset of breast cancer (often before age 50), increased chance ofbilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breastcancer among men, increased incidence of tumors of other specific organs, such as the prostate Defects in BRCA2 are the cause of Fanconi anemia complementation group D type 1 (FANCD1) [MIM:605724]. It is adisorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associatedwith cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development ofmalignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomalinstability (increased chromosome breakage) and defective DNA repair Defects in BRCA2 are a cause of glioma type 3 (GLM3) [MIM:613029]. Gliomas are benign or malignant centralnervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that arederived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes 20/119 diseases for BRCA2 (see all 119): About MalaCardsbreast-ovarian cancer fanconi anemia, complementation group d1 ovarian cancer fanconi's anemia breast cancer li-fraumeni-like syndrome tay-sachs disease li-fraumeni syndrome peutz-jeghers syndrome anemia von hippel-lindau disease pre-b-cell acute lymphoblastic leukemia fallopian tube carcinoma fallopian tube cancer breast-ovarian cancer, familial, 2 synchronous bilateral breast carcinoma diffuse large b-cell lymphoma bile duct cancer multiple endocrine neoplasia breast cancer, early-onset
14 diseases from the University of Copenhagen DISEASES database for BRCA2:Ovarian cancer Breast cancer Hereditary breast ovarian cancer Aplastic anemia Fallopian tube cancer Li-Fraumeni syndrome Pancreatic cancer Lynch syndrome Peritoneal carcinoma Ductal carcinoma in situ Prostate cancer Peutz-Jeghers syndrome Carcinoma Dysplastic nevus syndrome 10/93 Novoseek disease relationships for BRCA2 gene (see all 93) About this table
| Disease |
-log (P-Val) |
Hits |
PubMed IDs for Articles with Shared Sentences (# sentences) |
| ovarian cancer |
94.5 |
1150 |
10560359 (7), 17196508 (6), 12237285 (5), 19066131 (5) (see all 99) |
| breast cancer |
92.3 |
2276 |
9145678 (9), 11044354 (8), 18355772 (7), 10359546 (7) (see all 99) |
| prophylactic oophorectomy |
91.4 |
37 |
15863145 (5), 9148160 (3), 12023993 (3), 18341607 (2) (see all 25) |
| germ-line mutation |
89.9 |
143 |
10969800 (4), 17001151 (4), 14732925 (3), 10862052 (3) (see all 99) |
| bilateral breast cancer |
85.8 |
31 |
11556836 (3), 10573018 (2), 19649703 (2), 19372713 (2) (see all 18) |
| cancer |
81.2 |
585 |
19620486 (7), 14966099 (7), 10972993 (5), 10433620 (4) (see all 99) |
| fanconis anemia |
77.9 |
48 |
19530235 (3), 16243825 (3), 14559878 (2), 17200671 (2) (see all 29) |
| li-fraumeni syndrome |
71 |
6 |
10432928 (2), 11205230 (1), 10962444 (1), 20014426 (1) (see all 5) |
| cancer syndromes hereditary |
70.5 |
5 |
19140568 (1), 16237564 (1), 19825178 (1), 10667595 (1) (see all 5) |
| fallopian tube cancer |
69.4 |
6 |
16835424 (1), 12237285 (1), 15254695 (1), 19141781 (1) (see all 6) |
Genatlas disease: BRCA2 familial breast carcinoma,2,with a high incidence of male breast cancer,sporadic or familial,and oflaryngeal,prostate,ovarian carcinomas (see TSG13D) GeneTests: BRCA2 Fanconi AnemiaBRCA1 and BRCA2 Hereditary Breast/Ovarian Cancer Genetic Association Database (GAD): BRCA2 Human Genome Epidemiology (HuGE) Navigator: BRCA2 (733 documents) Tumor Gene Database (TGDB): BRCA2 Export disorders for BRCA2 gene to outside databases
|
Publications for BRCA2 gene (in
PubMed.
Associations of this gene to articles via
1Entrez Gene,
2UniProtKB/Swiss-Prot,
3HGNC,
4GAD,
5PharmGKB,
6HMDB,
7DrugBank,
8UniProtKB/TrEMBL,
9 Novoseek, and/or
10fRNAdb)
About This Section
|
PubMed articles for BRCA2 gene, integrated from 9 sources (see all 1888): (articles sorted by number of sources associating them with BRCA2) | |  | Utopia: connect your pdf to the dynamic world of online information |
- The DNA sequence and analysis of human chromosome 13. (PubMed id 15057823)1, 2, 3 Dunham A.... Ross M.T. (2004)
- Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood. (PubMed id 14670928)1, 2, 4 Hirsch B.... D'Andrea A.D. (2004)
- A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. (PubMed id 11062481)1, 2, 4 Healey C.S.... Ponder B.A.J. (2000)
- Somatic mutations in the BRCA2 gene and high frequency of allelic loss of BRCA2 in sporadic male breast cancer. (PubMed id 11948477)1, 2, 9 Kwiatkowska E.... Mackiewicz A. (2002)
- Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families. (PubMed id 14722926)1, 2, 9 Valarmathi M.T.... Das S.N. (2004)
- BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage. (PubMed id 15314155)1, 2, 9 Schoenfeld A.R....Aaronson S.A. (2004)
- Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. (PubMed id 15199141)1, 2, 9 Wang X.Z.... D'Andrea A.D. (2004)
- BRCA2 germline mutations in familial pancreatic carcinoma. (PubMed id 12569143)1, 2, 9 Hahn S.A....Bartsch D.K. (2003)
- A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancer. (PubMed id 14647210)1, 4, 9 Jakubowska A....Lubinski J. (2003)
- A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. (PubMed id 11857015)1, 4, 9 Antoniou A.C....Easton D.F. (2002)
|
External Searches for BRCA2 gene
(in PubMed,
OMIM, and NCBI Bookshelf) About This Section
|
|
Genome Databases showing BRCA2 gene
(According to
Entrez Gene,
HGNC,
AceView,
euGenes,
Ensembl,
miRBase,
ECgene,
Kegg,
and/or
H-InvDB)
About This Section
|
|
Other Databases showing BRCA2 gene
(According to HUGE)
About This Section
| -- |
Specialized Databases showing BRCA2 gene(According to PharmGKB,
ATLAS, HORDE, IMGT, LEIDEN, UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL, Wikipedia and/or GeneReviews via UniProtKB/Swiss-Prot) About This Section
|
| Name | Description |
| PharmGKB entry for BRCA2 | Pharmacogenomics, SNPs, Pathways | | ATLAS Chromosomes in Cancer entry for BRCA2 | Genetics and Cytogenetics in Oncology and Haematology | | Fanconi Anemia Mutation Database | http://www.rockefeller.edu/fanconi/mutate/jumpd1.html | | GeneReviews | http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/BRCA2 | | NIEHS-SNPs | http://egp.gs.washington.edu/data/brca2/ | | Wikipedia | http://en.wikipedia.org/wiki/BRCA2 |
|
| | |
About This Section
| Patent Information for BRCA2 gene: Search GeneIP for patents involving BRCA2
GeneCards and IP: Japan Patent Office Licenses GeneCards European Patent Office Licenses GeneCards Improving the IP Search
|
Products for BRCA2 gene(Antibodies, recombinant proteins, and assays from EMD Millipore, R&D Systems, OriGene, QIAGEN, GenScript, Cell Signaling Technology, SABiosciences, Novus Biologicals, Sino Biological, Enzo Life Sciences, Abcam, ProSpec, Uscn, Thermo Fisher Scientific, Gene Editing from DNA2.0, Clones from EMD Millipore, OriGene, GenScript, Sino Biological, DNA2.0, SwitchGear Genomics, Vector BioLabs, Cell lines from GenScript and LifeMap BioReagents, PCR Arrays from SABiosciences, Drugs and/or compounds from EMD Millipore, Tocris Bioscience, and/or
Enzo Life Sciences), In Situ Hybridization Assays from Advanced Cell Diagnostics About This Section
|
 | |
 | |
 |
| | | | Browse OriGene Antibodies | | OriGene shRNA RFP for BRCA2 | | OriGene 29mer shRNA kits in GFP-retroviral vector in human, mouse, rat for BRCA2 | | OriGene genome-wide validated SYBR primer pairs in human, mouse, rat for BRCA2 | | Browse OriGene Protein Over-expression Lysates | | Browse OriGene Fluorogenic Cell Assay Kits | | OriGene siRNA for BRCA2 | | OriGene 3'-UTR Clone for BRCA2 | | OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for BRCA2 | | OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for BRCA2 | | Browse OriGene GFP tagged cDNA clones in CMV expression vector | | Browse OriGene MicroRNA Expression Plasmids | | Browse OriGene basic RS shRNAs | | Browse OriGene validated miRNA SYBR primer pairs | | Browse OriGene full length recombinant human proteins expressed in human HEK293 cells | | OriGene custom cloning services - gene synthesis, subcloning, mutagenesis,
variant library, vector shuttling | | OriGene Custom Antibody Services for BRCA2 | | OriGene Custom Protein Services for BRCA2 | | OriGene Custom Immunoassay Development | | |
| |  |
 |
| | QIAGEN Custom miScript Target Protector blocks miRNA-binding site of in human, mouse, rat BRCA2 | | QIAGEN SeqTarget long-range PCR primers in human, mouse, rat for resequencing BRCA2 | | QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat BRCA2 | | QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat BRCA2 | | QIAGEN QuantiFast Probe-based Assays in human, mouse, rat BRCA2 | | QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat BRCA2 |
| |
 |  |  |  | |
| Antibodies & Assays for BRCA2  |
| | | Search Tocris compounds for BRCA2 |
| |  |  |  |  | | | | |
 |
 |
 |
 | | BRCA2 Proteins, Antibodies, CLIAs, and ELISAs |
| | | | Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for BRCA2 |
|  |  |  | | | ThermoFisher Antibodies for BRCA2 |
| | Search Vector BioLabs for ready-to-use adenovirus/AAV for human, mouse, rat BRCA2 |
|
|
|
|